398 related articles for article (PubMed ID: 25502158)
1. Metformin use and the risk of esophageal cancer in Barrett esophagus.
Agrawal S; Patel P; Agrawal A; Makhijani N; Markert R; Deidrich W
South Med J; 2014 Dec; 107(12):774-9. PubMed ID: 25502158
[TBL] [Abstract][Full Text] [Related]
2. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
[TBL] [Abstract][Full Text] [Related]
4. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
[TBL] [Abstract][Full Text] [Related]
5. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
Corey KE; Schmitz SM; Shaheen NJ
Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
[TBL] [Abstract][Full Text] [Related]
7. Dysplasia in Barrett esophagus.
Lao CD; Simmons M; Syngal S; Bresalier RS; Fortlage L; Normolle D; Griffith KA; Appelman HD; Brenner DE
Cancer; 2004 Apr; 100(8):1622-7. PubMed ID: 15073848
[TBL] [Abstract][Full Text] [Related]
8. Controversies in Barrett esophagus.
Dunbar KB; Spechler SJ
Mayo Clin Proc; 2014 Jul; 89(7):973-84. PubMed ID: 24867396
[TBL] [Abstract][Full Text] [Related]
9. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus.
Coleman HG; Bhat S; Johnston BT; McManus D; Gavin AT; Murray LJ
Gastroenterology; 2012 Feb; 142(2):233-40. PubMed ID: 22062359
[TBL] [Abstract][Full Text] [Related]
10. Endoluminal therapy for esophageal disease: an introduction.
Wolfsen HC
Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):1-10, v. PubMed ID: 19951790
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma and Barrett's esophagus. An overrated risk?
Spechler SJ; Robbins AH; Rubins HB; Vincent ME; Heeren T; Doos WG; Colton T; Schimmel EM
Gastroenterology; 1984 Oct; 87(4):927-33. PubMed ID: 6468881
[TBL] [Abstract][Full Text] [Related]
13. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
14. Management of Barrett's esophagus: cases and questions.
Bresalier R
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
[TBL] [Abstract][Full Text] [Related]
15. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
Morgan G
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
[No Abstract] [Full Text] [Related]
16. Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow?
Hur C
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):307-9. PubMed ID: 17257904
[No Abstract] [Full Text] [Related]
17. The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.
Chang EY; Morris CD; Seltman AK; O'Rourke RW; Chan BK; Hunter JG; Jobe BA
Ann Surg; 2007 Jul; 246(1):11-21. PubMed ID: 17592284
[TBL] [Abstract][Full Text] [Related]
18. Barrett esophagus: diagnostic challenges.
Hagen CE; Lauwers GY; Mino-Kenudson M
Semin Diagn Pathol; 2014 Mar; 31(2):100-13. PubMed ID: 24815936
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for esophageal cancer development.
Falk GW
Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
[TBL] [Abstract][Full Text] [Related]
20. The relationship between smoking and severe dysplastic disease in patients with Barrett's columnar-lined oesophagus.
Ramus JR; Gatenby PA; Caygill CP; Watson A; Winslet MC
Eur J Cancer Prev; 2012 Nov; 21(6):507-10. PubMed ID: 22433630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
